Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate

CAS: 105655-17-2

Ref. 3D-FEA65517

Produktinformation

• Name: Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate

Beschreibung

Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate is a lead compound for the treatment of cancer. It binds to bromodomains, which are domains in the cell that bind to bromine, and inhibits the function of these domains. Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate has been shown to inhibit tumor growth in vivo and in vitro by inhibiting the proliferation of cancer cells. This drug also has antiangiogenic properties, which may be due to its ability to inhibit tumor vascularization by blocking specific proangiogenic signaling pathways. Methyl 4-amino-3-bromo-5-nitrobenzenecarboxylate is an endogenous molecule that can be synthesized from methyl 3-(2,4,6,-trimethoxybenzoyl) benzoate and 3-(2

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 275.06 g/mol
• Formel: C₈H₇BrN₂O₄
• Reinheit: Min. 95%